Stockreport

Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women [Yahoo! Finance]

Rallybio Corporation  (RLYB) 
PDF pregnant women and thereby eliminate the risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) and its potentially devastating consequences in their fetuses and [Read more]